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Staphylococcus epidermidis developed to be a significant human 
pathogen due to the ability to produce biofilm. The most significant 
infections of  S.epidermidis found in the use of medical devices such as an 
intravenous catheter. Furthermore, the biofilm is more resistant to 
antibiotics up to 1000 times more than free-bacteria. This simple survey 
aimed to describe the profile of biofilm-producing S. epidermidis from 
intravenous catheter colonisation of some patients in surgical and internal 
medicine wards at the Margono Soekarjo hospital, Purwokerto, and the 
antibiotics resistance pattern. A vitek® 2 compact (Enseval Medika Prima) 
was performed to identify the bacterial species and to examine 73 
antibiotics for understanding the resistance pattern automatically. The 
optical density (OD) representing the ability of S. epidermidis to produce 
biofilms was measured by Microtiter plate biofilm assay with crystal violet 
staining. A scanning electron microscopy was done to compare the 
thickness of the ultrastructure of biofilm-producing S. epidermidis visually. 
The present study found that 2 of 8 Gram-positive bacteria (25%) were 
biofilm-producing S. epidermidis.  One of S. epidermidis was moderate 
whereas the other was high biofilm-producing bacteria. Images of SEM 
showed that a high biofilm-producing S. epidermidis has a thicker 
ultrastructure of biofilm than the moderate biofilm-producing, whereas a 
control, the weak biofilm-producing  S. epidermidis ATCC 12228 has the 
least biofilm. Both of S. epidermidis strains were sensitive to Gentamicin, 
Moxifloxacin, Quinupristin/Dalfopristin, Linezolid, Vancomycin, 
Doxycycline, Minocycline, Tetracycline, Tigecycline, and Nitrofurantoin. 
Furthermore, both S. epidermidis strains were resistant to the other (63) 
antibiotics. In conclusion, two strains of S. epidermidis in this study have 
different capabilities to form the biofilm which showed that high biofilm-
producing strain was thicker than moderate biofilm-producing strain by 
scanning electron microscopy. However, both of them were resistant to the 
same number of antibiotics.  
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INTRODUCTION  
Medical devices-associated infection 
potentially cause some severe clinical problems. In 
general, phagocyte activity and polymorpho-
nuclear leukocytes decrease in the use of invasive 
medical devices. For that reason, when 
microorganisms   have a  chance  to  reach  medical  
devices surface, they will be attached, and biofilm 
formation can arise (Gottenbos et al., 2002). The 
use of invasive medical devices such as 
intravenous catheters is a risk factor for 
Staphylococcus sp. particularly Staphylococcus 
epidermidis in growing up in a biofilm stage 
(Fitzpatrick et al., 2005). 
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MATERIAL AND METHODS 
Bacterial species and antibiotics susceptibility 
 
The bacterial strains were isolated from 39  
proximal tips of the intravenous catheters from 
the patients in surgical and internal medicine 
wards of Prof. Dr Margono Soekarjo hospital, 
Purwokerto,  on July-August,  2014.  Isolates  were 
taken from the piece of the intravenous catheter 
proximal tips at the catheter removal process 
aseptically. The proximal catheter tip is the site of 
catheter insertion in the blood vessels of a patient 
who can act as a port d'entry of infections 
(O’Grady et al., 2011). Isolates were not taken 
from other parts of the intravenous catheter such 
as the urine bag because they were directly 
related to the vein and were sterile. 
A vortex and viable count method were 
performed to measure intraluminal and 
extraluminal biofilm (Donlan and Costerton, 
2002). Briefly, about  3 cm of the proximal tip of 
the intravenous catheter in the sterile aquadest 
was vortexed for 2min. The isolates were cultured 
on the blood agar (OXOID) plate at 37°C for 24h  
(overnight culture). A vitek® 2 compact (Enseval 
Medika Prima) was performed to identify the 
bacterial species and to examine the antibiotics 
resistance. Antimicrobial Susceptibility Testing 
(AST) done by a vitek® 2 compact (Enseval 
Medika Prima) be able to used to predict                   
how pathogens will respond to particular 
antimicrobials automatically (Blondel-Hill et al., 
2006). Therefore, data obtained by using this tool 
are data about bacterial species and data of 
antibiotics sensitivity along with its MIC value.   
As many as 73 antibiotics tested include 
Cefoxitin, Flomoxef, Latamoxef, Benzylpenicillin, 
Nafcillin, Amoxicillin, Ampicillin, Carbenicillin, 
Ticarcillin, Azlocillin, Mezlocillin, Piperacillin, 
Piperacillin/Tazobactam, Cloxacillin, Dicloxa-cillin, 
Flucloxacillin, Methicillin, Oxacillin, Cefaclor, 
Cefadroxil, Cefalexin, Cefalotin, Cefazolin, Cefeta-
met, Cefonicid, Cefprozil, Cefradine, Cephapirin, 
Loracarbef, Cefamandole, Cefpodo-xime, Cefti-
buten, Cefmenoxime, Cefoperazone, Cefotaxime, 
Ceftazidime, Ceftizoxime, Ceftriaxone, Cefepime, 
Cefpirome, Doripenem, Ertapenem, Faropenem, 
Imipenem, Meropenem, Gentamicin High Level,  
Streptomycin High Level, Gentamicin, Cipro-
floxacin, Levofloxacin, Moxifloxacin, Inducible 
Clindamycin Resistance, Azithromycin, Clarithro-
mycin, Erythromycin, Clindamycin, Quinupristin 
/Dalfopristin, Linezolid, Vancomycin, Doxy-
cycline, Cefuroxime, Cefmetazole, Cefotetan, 
Cefoxitin, Cefdinir, Cefditoren, Cefixime, Mino-
cycline, Tetracycline, Tigecycline, Nitrofurantoin, 
Rifampicin, Trimethoprim / Sulfamethoxazole. 
The isolates stored in Tryptic Soy Broth (TSB, 
OXOID) and 15% glycerol in - 80°C. 
 
Biofilm assay 
Biofilm optical density (OD) was measured 
by using microtiter plate biofilm assay with crystal 
violet staining, as done previously with some 
modification (Anjarwati et al., 2017; Merritt et al., 
2011). The values of OD describe an index of 
biofilms formation. Briefly, after a dilution (1:100) 
in fresh Tryptic Soy Broth, the bacteria from the 
overnight cultures in Tryptic Soy Broth and the 
20μL of cultures were inoculated into fresh 
Tryptic Soy Broth (200μL) in each well. After 24h 
of incubation at 37°C, each well was washed off 
three times by using phosphate buffer saline  
(PBS), OXOID, pH 7.3 to remove planktonic 
bacteria. Then the adherent bacteria stained with 
100μL 1% crystal violet. After which, 5% acid 
Isopropanol  (5% v/v 1M HCl in 2-propanol) 
added in each   well.   The   absorbance at an 
appropriate range  wavelength (630nm) was 
determined to measure the stained biofilms 
quantitatively by using a microplate reader 
(ELX800, Bio-Tek instruments). 
 
Scanning electron microscopy  
Scanning electron microscopy was 
implemented to compare the thickness of biofilm-
producing S. epidermidis strains ultrastructure 
visually. Briefly, S.epidermidis ATCC35984 from 
the overnight cultures in TSB then diluted in TSB 
(1:100).  Moreover, as much as 50µL cultures 
inoculated into 13mm sterile coverslips (Thermo 
Scientific Nunc),  which laid on the bottom of 6 
wells plate with  TSB  (5mL) in each well. Each 
well was washed three times with PBS to 
eliminate free-cells following 24h incubation 
(37ᵒC). Furthermore, the cover glass was 
immersed in 70% methanol for 20min at room 
temperature for fixation; then, it was dried 
overnight at room temperature. Finally, the dry 
cover glasses were coated twice with platinum 
vanadium by using sputter ion. Before observed 
by using SEM, the cover glasses attached to the 
double-side tape carbon (Anjarwati et al., 2017; 
Setiawan et al., 2012) 
 
Data analysis 
Profile of biofilm-producing S. epidermidis 
in this study was analysed descriptively using the 
univariate method. The interpretation of the 
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biofilm production has used a formulation of 
optical density cut-off value (ODc) = average OD of 
negative control + 3 x SD of the negative control. 
The criteria :  Non/weak  ≤ ODc / ODc < ~ ≤ 2x 
ODc ; Moderate 2x ODc < ~ ≤ 4x ODc ;  high > 4x 
ODc (Hassan et al., 2011). Meanwhile, the MIC 
value of each antibiotic tested was obtained 
automatically from the vitek® 2 compact results. 
 
Ethics 
This study approved by the health research 
ethics committee of the medical faculty of 
Diponegoro University and Kariadi hospital, 
Semarang. 
 
RESULTS AND DISCUSSION 
In the present study, the isolates were taken 
from 39 proximal tips of the intravenous catheter 
of patients in the surgery and internal medicine 
wards of Prof. Dr Margono Soekarjo hospital, 
Purwokerto. After vortex and viable count method, 
species identification done by a vitek® 2 compact 
as well an antibiotic sensitivity test. To determine 
biofilms optical density (OD), a microtiter                  
plate biofilm assay by using staining of crystal 
violet was performed. Then, the thickness of 
biofilm ultrastructure compared by using SEM 
visually. 
S. epidermidis found was 2 of 8 Gram-
positive bacteria (25%). The type of all bacteria 
has published as a poster in a previous 9th 
National  Symposium of IARW and annual 
scientific meeting of Indonesian Society for 
Clinical Microbiology. The other bacteria were S. 
haemolyticus (1),  S. hominis (2), E.faecium  (1), K. 
rosea (1), L mesenterdfghgdfhoides (1) (Anjarwati 
et al., 2014).   This   paper   present    mainly  the  
potency  of S. epidermidis to produce biofilm. Both 
S. epidermidis were biofilm-producing bacteria, 
one of them was moderate (Se2) whereas the 
other was a high (Se1) biofilm-producing bacteria. 
The ODc value in  this study was 0.12. A moderate 
biofilm-producing bacteria has the optical density 
range of 0.2422 <...≤ 0.4844. Meanwhile, a high 
biofilm-producing bacteria has an optical density 
of more than 0.4844. This study found differences 
in optical density between Se1 and Se2 biofilms 
(Figure 1).  
Furthermore, SEM  showed the different 
thickness of the biofilm ultrastructure (Figure 2).  
High biofilm-producing S. epidermidis consist of 
more layers biofilm than moderate biofilm.  
Meanwhile, the control bacteria, S. epidermidis 
ATCC 12228, a weak biofilm-producing bacteria 
showed only a small number of biofilm. 
In this simple survey by using vitek® 2 
compact  automatically reported that both S. 
epidermidis (100%)  sensitive to  Gentamicin, 
Moxifloxacin, Quinupristin / Dalfopristin, Line-
zolid, Vancomycin, Doxycycline, Minocycline, 
Tetracycline, Tigecycline, and Nitrofurantoin 
(Figure 3). Whereas both of S. epidermidis (100%) 
was resistance to the other 86.3% (63 of 73)  
antibiotics. 
 
This study presents the profile of biofilm-
producing S. epidermidis (Figures 1 dan 2). The 
results indicated that in this study biofilm-
producing S. epidermidis were found as 
colonisation on the intravenous catheter. 
Colonisation is a critical point of medical devices 
associated with infection. Additionally, the fragile 
steadiness of colonisation and infection is 
frequently sustained for months (Fux et al., 2009). 
As a biofilm-producing bacteria, S. epidermidis then 
can adhere to a surface in the initiation phase, 
followed by formation of microcolonies, which 
grow into a mature biofilm structure to disperse 
phase (Agarwal et al., 2010). 
There are no standardised procedures thus 
far used regularly to define the antibiotic 
sensitivity of biofilms-producing bacteria               
(Estela and Alejandro, 2012). In some cases, 
antibiograms showed susceptibility against some 
microorganisms from medical devices, but that 
medical devices associated infection fail to be 
eliminated by the same antibiotics (Fux et al., 
2005). In this study, the antibiotic sensitivity              
test done by a vitek® 2 Compact. The sensitivity 
test and identification of species carried                         
out automatically at the same time. The 
advantages of this tool are practical and useful in 
detecting species. However, sensitivity test data 
obtained for species that are not pathogenic was 
incomplete, such as data of MIC. Both S. 
epidermidis strains, either it produces a moderate 
or a high biofilm, are resistant to the same 
antibiotics. 
This study revealed that two strain  of                     
S. epidermidis (100%) sensitive to Gentamicin 
(aminoglycoside), Moxifloxacin (quinolone), 
Quinupristin/ Dalfopristin (streptogramin), 
Linezolid (oxazolidinone), Vancomycin 
(glycopeptide), Tigecycline (glycylcycline), 
Nitrofurantoin and three kinds of tetracycline 
(Doxycycline, Minocycline, Tetracycline), but 
resistant   to  other  63 of  73   (86.3%)  antibiotics.  
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The antibiotics resistance mechanisms of biofilms 
and planktonic bacteria are different. The 
antibiotics resistance mechanisms  in planktonic 
bacteria consist of efflux pumps, modifying 
enzymes, target mutations outer membrane 
impermeability (Estela and Alejandro, 2012; 
Poole, 2002). Meanwhile, biofilm-producing 
bacteria has been presented to have their intrinsic 
mechanisms of resistance. Multi mechanisms 
suggested to account for antibiotic resistance of 
biofilm bacteria such as the low or incomplete 
penetration of the antibiotics into biofilm, a 
chemical micro environment alteration within the 
biofilm, counter balancing enzymatic, functional 
hetero-geneity, slow growth and persistent cells 
and the modification of biofilm phenotype due to  
adaptive  mechanisms to  stress   (such as efflux 
pumps and alterations in the membrane). 
Consequently, these mechanisms should be 
measured to explain therapeutic failure in the 
management of patients for whom laboratory 
outcomes show proper sensitivity patterns (Estela 
and Alejandro, 2012). 
Data of infections caused by biofilm-
producing bacteria particularly in the use of 
invasive medical devices have not been found 
widely in Indonesia. Studies and publications 
associated with these infections nationally                 
 
 
Figure 1. Biofilm-producing S. epidermidis  (1= strain 1 of S. epidermidis (Se1),  High biofilm-producing           
S. epidermidis,  2 =  Strain 2 of S. epidermidis (Se2), moderate biofilm-producing S. epidermidis )  ODc = 
0,12 (Moderat :  0.2422 < …. ≤  0.4844;  High :   > 0.4844). 
 
 
 
 
Figure 2. Images of SEM. A. High biofilm-producing S. epidermidis (Se1); B. Moderate biofilm-producing S. 
epidermidis (Se2); C. Weak biofilm-producing S. epidermidis ATCC 12228. Magnification: 20.000 X.  
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need to be improved. The difference between  the 
resistance mechanisms of planktonic bacteria and 
biofilm bacteria is an interesting point for 
researchers to investigate this phenomenon. 
 
CONCLUSION 
Two clinical strains of S. epidermidis from 
the patients in surgical and internal medicine 
wards at Prof. Dr Margono Soekarjo hospital, 
Purwokerto have different capabilities to form the 
biofilm which showed that high biofilm-producing 
strain was thicker than moderate biofilm-
producing strain by scanning electron microscopy. 
However, both of them were resistant to the same 
number of antibiotics.  
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